Focus on PTEN Regulation

Overview

Journal Front Oncol

Specialty Oncology

Date 2015 Aug 19

PMID 26284192

Citations 73

Authors

Miriam Bermudez Brito

Evangelia Goulielmaki

Evangelia A Papakonstanti

Affiliations

Soon will be listed here.

Abstract

The role of phosphatase and tensin homolog on chromosome 10 (PTEN) as a tumor suppressor has been for a long time attributed to its lipid phosphatase activity against PI(3,4,5)P3, the phospholipid product of the class I PI3Ks. Besides its traditional role as a lipid phosphatase at the plasma membrane, a wealth of data has shown that PTEN can function independently of its phosphatase activity and that PTEN also exists and plays a role in the nucleus, in cytoplasmic organelles, and extracellularly. Accumulating evidence has shed light on diverse physiological functions of PTEN, which are accompanied by a complex regulation of its expression and activity. PTEN levels and function are regulated transcriptionally, post-transcriptionally, and post-translationally. PTEN is also sensitive to regulation by its interacting proteins and its localization. Herein, we summarize the current knowledge on mechanisms that regulate the expression and enzymatic activity of PTEN and its role in human diseases.

Citing Articles

Pharmacological modulation of PI3K/PTEN/Akt/mTOR/ERK signaling pathways in ischemic injury: a mechanistic perspective.

Khan H, Singh A, Singh Y, Sharma D, Dua K, Grewal A Metab Brain Dis. 2025; 40(3):131.

PMID: 40009091 DOI: 10.1007/s11011-025-01543-8.

Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer.

Ajayi A, Oyovwi M, Akano O, Akanbi G, Adisa F Cancer Cell Int. 2025; 25(1):33.

PMID: 39901204 PMC: 11792371. DOI: 10.1186/s12935-025-03658-5.

Case report: Exploring Lynch Syndrome through genomic analysis in a mestizo Ecuadorian patient and his brother.

Guevara-Ramirez P, Ruiz-Pozo V, Cadena-Ullauri S, Paz-Cruz E, Tamayo-Trujillo R, Gaviria A Front Med (Lausanne). 2025; 11:1498290.

PMID: 39741510 PMC: 11685006. DOI: 10.3389/fmed.2024.1498290.

Reversing Persistent PTEN Activation after Traumatic Brain Injury Fuels Long-Term Axonal Regeneration via Akt/mTORC1 Signaling Cascade.

Shi Z, Mao L, Chen S, Du Z, Xiang J, Shi M Adv Sci (Weinh). 2024; 12(6):e2410136.

PMID: 39680734 PMC: 11809353. DOI: 10.1002/advs.202410136.

The Delivery of Mimic miRNA-7 into Glioblastoma Cells and Tumour Tissue by Graphene Oxide Nanosystems.

Kutwin M, Sosnowska-Lawnicka M, Nasilowska B, Lange A, Wierzbicki M, Jaworski S Nanotechnol Sci Appl. 2024; 17:167-188.

PMID: 39280996 PMC: 11402368. DOI: 10.2147/NSA.S469193.

References

Yang C, Li S, Wang M, Chang A, Liu Y, Zhao F . PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha. Mol Cancer. 2013; 12:21. PMC: 3610140. DOI: 10.1186/1476-4598-12-21. View

Fan C, He L, Kapoor A, Rybak A, De Melo J, Cutz J . PTEN inhibits BMI1 function independently of its phosphatase activity. Mol Cancer. 2009; 8:98. PMC: 2777864. DOI: 10.1186/1476-4598-8-98. View

Ye B, Jiang L, Xu H, Zhou D, Li Z . Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis. Int J Immunopathol Pharmacol. 2012; 25(3):627-36. DOI: 10.1177/039463201202500309. View

Song M, Carracedo A, Salmena L, Song S, Egia A, Malumbres M . Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell. 2011; 144(2):187-99. PMC: 3249980. DOI: 10.1016/j.cell.2010.12.020. View

Vazquez F, Ramaswamy S, Nakamura N, Sellers W . Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol. 2000; 20(14):5010-8. PMC: 85951. DOI: 10.1128/MCB.20.14.5010-5018.2000. View

Lou Y, Yang X, Wang F, Cui Z, Huang Y . MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med. 2010; 26(6):819-27. DOI: 10.3892/ijmm_00000530. View

Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B . The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010; 11(5):329-41. DOI: 10.1038/nrm2882. View

Bononi A, Pinton P . Study of PTEN subcellular localization. Methods. 2014; 77-78:92-103. PMC: 4396696. DOI: 10.1016/j.ymeth.2014.10.002. View

Song M, Salmena L, Pandolfi P . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012; 13(5):283-96. DOI: 10.1038/nrm3330. View

10.

Edwin F, Singh R, Endersby R, Baker S, Patel T . The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation. J Biol Chem. 2005; 281(8):4816-22. DOI: 10.1074/jbc.M508300200. View

11.

Meuillet E, Mahadevan D, Berggren M, Coon A, Powis G . Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys. 2004; 429(2):123-33. DOI: 10.1016/j.abb.2004.04.020. View

12.

Howitt J, Lackovic J, Low L, Naguib A, Macintyre A, Goh C . Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. J Cell Biol. 2012; 196(1):29-36. PMC: 3255971. DOI: 10.1083/jcb.201105009. View

13.

Song M, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J . The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature. 2008; 455(7214):813-7. PMC: 3398484. DOI: 10.1038/nature07290. View

14.

Xu D, Yao Y, Jiang X, Lu L, Dai W . Regulation of PTEN stability and activity by Plk3. J Biol Chem. 2010; 285(51):39935-42. PMC: 3000975. DOI: 10.1074/jbc.M110.166462. View

15.

He L, Ingram A, Rybak A, Tang D . Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J Clin Invest. 2010; 120(6):2094-108. PMC: 2877943. DOI: 10.1172/JCI40778. View

16.

Liu C, Yu J, Yu S, Lavker R, Cai L, Liu W . MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol. 2010; 53(1):98-107. DOI: 10.1016/j.jhep.2010.02.021. View

17.

van den Berg A, Mols J, Han J . RISC-target interaction: cleavage and translational suppression. Biochim Biophys Acta. 2008; 1779(11):668-77. PMC: 2646505. DOI: 10.1016/j.bbagrm.2008.07.005. View

18.

Mistafa O, Ghalali A, Kadekar S, Hogberg J, Stenius U . Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases. J Biol Chem. 2010; 285(36):27900-10. PMC: 2934657. DOI: 10.1074/jbc.M110.117093. View

19.

Miska E . How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005; 15(5):563-8. DOI: 10.1016/j.gde.2005.08.005. View

20.

Virolle T, Adamson E, Baron V, Birle D, Mercola D, Mustelin T . The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol. 2002; 3(12):1124-8. DOI: 10.1038/ncb1201-1124. View